News of Note—Altimmune’s new CEO, Scripps’ HIV vaccine and more

newspaper
(Pixabay)

Here is some other vaccine news of note for the week:

> Altimmune has poached Neos Therapeutics’ CEO, Vipin Crag, Ph.D., to succeed Bill Enright as its president and CEO. Release

> Scripps Research scientists have found a way to stabilize HIV envelope protein for a new HIV vaccine. The candidate elicited robust anti-HIV antibody responses in mice and rabbits, the team reported. Release

> The NIH awarded Tulane University School of Medicine a contract worth up to $8.5 million to develop a more effective and longer-lasting vaccine against whooping cough. Release